0001144204-18-062852.txt : 20181203
0001144204-18-062852.hdr.sgml : 20181203
20181203160156
ACCESSION NUMBER: 0001144204-18-062852
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181129
FILED AS OF DATE: 20181203
DATE AS OF CHANGE: 20181203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jantzen Beth
CENTRAL INDEX KEY: 0001633940
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36745
FILM NUMBER: 181214013
MAIL ADDRESS:
STREET 1: C/O APPLIED DNA SCIENCES, INC.
STREET 2: 50 HEALTH SCIENCES DRIVE
CITY: STONY BROOK
STATE: NY
ZIP: 11790
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC
CENTRAL INDEX KEY: 0000744452
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
IRS NUMBER: 592262718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 50 HEALTH SCIENCES DRIVE
CITY: STONY BROOK
STATE: NY
ZIP: 11790
BUSINESS PHONE: 631-240-8800
MAIL ADDRESS:
STREET 1: 50 HEALTH SCIENCES DRIVE
CITY: STONY BROOK
STATE: NY
ZIP: 11790
FORMER COMPANY:
FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC
DATE OF NAME CHANGE: 20010504
FORMER COMPANY:
FORMER CONFORMED NAME: DCC ACQUISITION CORP
DATE OF NAME CHANGE: 19990211
FORMER COMPANY:
FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/
DATE OF NAME CHANGE: 19980306
4
1
tv508165_4.xml
FORM 4
X0306
4
2018-11-29
0
0000744452
APPLIED DNA SCIENCES INC
APDN
0001633940
Jantzen Beth
50 HEALTH SCIENCES DRIVE
STONY BROOK
NY
11790
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
6.96
2018-11-29
4
D
0
4167
0
D
2018-11-29
Common Stock
4167
0
D
Stock Option (right to buy)
6.96
2018-11-29
4
A
0
4167
0
A
2018-11-29
2023-11-28
Common Stock
4167
4167
D
The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from November 29, 2018 to November 28, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 29, 2013 and provided for vesting (i) with respect to 25% of the underlying shares on the anniversary of the original grant date and (ii) with respect to the remaining underlying shares, ratably each anniversary thereafter until fully vested on the fourth anniversary of the original date of grant.
/s/ Beth Jantzen
2018-12-03